Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease.
about
Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's diseaseDesign and discovery of mushroom tyrosinase inhibitors and their therapeutic applications.Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremiaDirect intranigral injection of dopaminochrome causes degeneration of dopamine neuronsTyrosinase-expressing neuronal cell line as in vitro model of Parkinson's disease.The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's diseaseMelanin affinity and its possible role in neurodegeneration.Neuromelanin of the human substantia nigra: an update.Protective and toxic roles of dopamine in Parkinson's disease.The early molecular processes underlying the neurological manifestations of an animal model of Wilson's disease.Melanin and neuromelanin binding of drugs and chemicals: toxicological implications.Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors.Combined kinetic studies and computational analysis on kojic acid analogous as tyrosinase inhibitors.Neuroprotective effects of 3α-acetoxyeudesma-1,4(15),11(13)-trien-12,6α-olide against dopamine-induced apoptosis in the human neuroblastoma SH-SY5Y cell line.Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways.Human tyrosinase produced in insect cells: a landmark for the screening of new drugs addressing its activity.Identification of the minimal melanocyte-specific promoter in the melanocortin receptor 1 gene.The reaction of alpha-synuclein with tyrosinase: possible implications for Parkinson disease.Prospective neurobiological effects of the aerial and root extracts and some pure compounds of randomly selected Scorzonera species.Antioxidant activity, acetylcholinesterase and tyrosinase inhibitory potential of Pulmonaria officinalis and Centarium umbellatum extracts.α-Synuclein facilitates the toxicity of oxidized catechol metabolites: Implications for selective neurodegeneration in Parkinson's disease
P2860
Q34313803-8DAEFBD1-C9B7-4D52-B16F-199696920AD2Q34413999-15102E7E-06D0-40D7-B49D-75D219F770B2Q34735331-D2FC9145-66C5-4AF8-ABB1-50C6F9EE83BDQ36505602-F714910F-FC02-48F5-BF35-911AB7D89187Q37755995-7880BE41-9ECD-46C4-8DF2-A8266946A5FEQ37845675-3E7AF0D2-DC95-46D3-B725-F2800BD65FF7Q38118939-81224C67-1C88-4BC0-B6AC-7A76EC24CB6EQ38155132-6BB56FB8-5829-4C66-A153-43B24CA1C15AQ38189127-A7344752-ACE4-4E18-8151-C472DE8CE289Q38491412-14F4D94C-B529-4C7E-AC04-0BFD420CB4F8Q38867426-77EB0C03-C4CF-42D7-A4E5-78E6727E479AQ39093314-BB51CAF0-EF0B-4E8F-B6F5-084424867B15Q39162889-500948CB-0A84-42A3-94B2-3D25C1FC697DQ39521597-5FDBD07E-3E7D-4E27-8E73-5E31CCF37E81Q40016819-34DD8456-BF56-4BAD-A720-DD31B936C09AQ42193034-6AB61560-A453-4EE6-89D5-40D5022C698EQ42760422-869CA97D-5053-4CB8-A61F-067E1E49286CQ46663033-F7FA112C-2427-4D57-992D-8E1BADF52AFAQ46880791-76333146-D2A2-4450-876D-200BAC39D689Q55105523-BFB3B685-B41C-41CC-826B-D72A5FEE320DQ57341699-C855A26B-06C9-4D29-AAFE-80DCE73D483A
P2860
Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Tyrosinase exacerbates dopamin ...... ated with Parkinson's disease.
@en
Tyrosinase exacerbates dopamin ...... ated with Parkinson's disease.
@nl
type
label
Tyrosinase exacerbates dopamin ...... ated with Parkinson's disease.
@en
Tyrosinase exacerbates dopamin ...... ated with Parkinson's disease.
@nl
prefLabel
Tyrosinase exacerbates dopamin ...... ated with Parkinson's disease.
@en
Tyrosinase exacerbates dopamin ...... ated with Parkinson's disease.
@nl
P2093
P2860
P50
P1476
Tyrosinase exacerbates dopamin ...... ated with Parkinson's disease.
@en
P2093
Alexandra Beilina
David W Miller
Donald Carter
Elisa Greggio
Elisabetta Bergantino
Gertrude-Emilia Costin
Johanna Eerola
Olli Hellström
Pentti J Tienari
Rili Ahmad
P2860
P304
P356
10.1111/J.1471-4159.2005.03019.X
P407
P577
2005-04-01T00:00:00Z